It is a pharma private limited company based in Pune, Maharashtra, India, established in 2017.
2017 | Pune, Maharashtra, India | ActiveEpinova Therapeutics Private Limited, a active private limited company, was established on 29 August 2017 in Pune, Maharashtra, India. Engaging in pharmaceutical retailers & distributors within the manufacturing sector, it holds CIN: U74999PN2017PTC172251. Registered under ROC Roc Pune. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.
It upholds a compliant status. Its leadership includes Balwant Pandurangrao Golegaonkar (Director), Samir Pandharinath Mulkar (Director), Atul Sheshadri Kulkarni (Director). Past directors included Balwant Pandurangrao Golegaonkar. Its latest AGM occurred on 30 December 2020, with the balance sheet filed on 31 March 2020. It is based at S.N. 116/12150153A Fl-9 Nr Mohanwadi, Samarth Park / Yerawada, Pune, Maharashtra, 411006.
U74999PN2017PTC172251
172251
29 August 2017
₹0.10 M
₹0.10 M
Roc Pune
Unlisted
Active
Explore comprehensive insights into Epinova Therapeutics Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Balwant Pandurangrao Golegaonkar | Director | 07 Feb 2018 | Current |
| Samir Pandharinath Mulkar | Director | 29 Aug 2017 | Current |
| Atul Sheshadri Kulkarni | Director | 29 Aug 2017 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 31 Dec 2018 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Epinova Therapeutics Private Limited, for the financial year ended 2020, experienced significant growth in revenue, with a 40.86% increase. The company also saw a substantial improvement in profitability, with a 569.55% increase in profit. The company's net worth Soared by an impressive increase of 129.25%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2020, Epinova Therapeutics had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Epinova Therapeutics, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Epinova Therapeutics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Epinova Therapeutics's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Epinova Therapeutics Private Limited last Annual general meeting of members was held on 30 Dec 2020 as per latest MCA records. was completed.
The activity Epinova Therapeutics Private Limited has filed its annual Financial statements for the year ended 31 Mar 2020 with Roc Pune. was completed.
Balwant Pandurangrao Golegaonkar was appointed as a Director was appointed as a Director on 07 Feb 2018 & has been associated with this company since 7 years 9 months . was recorded as a recent event.
Samir Pandharinath Mulkar was appointed as a Director was appointed as a Director on 29 Aug 2017 & has been associated with this company since 8 years 3 months . was recorded as a recent event.
Progress on Atul Sheshadri Kulkarni was appointed as a Director was appointed as a Director on 29 Aug 2017 & has been associated with this company since 8 years 3 months . was documented.
Progress on Epinova Therapeutics Private Limited was registered on 29 Aug 2017 with Roc Pune & aged 8 years 3 months as per MCA records. was documented.
The CIN of Epinova Therapeutics Private Limited is U74999PN2017PTC172251.
Epinova Therapeutics Private Limited is headquartered at S.N. 116/12150153A Fl-9 Nr Mohanwadi, Samarth Park / Yerawada, Pune, Maharashtra, 411006.
Epinova Therapeutics Private Limited was incorporated on 29 August 2017.
The current directors of Epinova Therapeutics Private Limited are
The primary industry of Epinova Therapeutics Private Limited is Manufacturing.
Epinova Therapeutics Private Limited is unlisted.
The authorized capital of Epinova Therapeutics Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.
The compliance status of Epinova Therapeutics Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX